Share Prices & Company Research

Market News

25 Jul 2018 | 14:33

Alliance Pharma sees revenue rising 10%, with slower rate of profit growth

Specialty pharmaceuticals group Alliance Pharma said it expected to post a 10% rise in first-half revenue, though the rate of profit growth would be lower due to spending on sales and marketing.

Revenue for the six months through June was seen growing to £54.5m, the company said.

'On the basis of trading in the year to date, the board expects revenue and underlying profit before tax for the current financial year to be in line with expectations,' it added.

On a constant currency basis, sales would have increased by 12% and, excluding acquisitions, sales would have increased 4%.

At 2:33pm: (LON:APH) Alliance Pharma PLC share price was -3p at 91p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.